154 related articles for article (PubMed ID: 24742661)
1. Circulating concentrations of soluble receptor for AGE are associated with age and AGER gene polymorphisms in children with newly diagnosed type 1 diabetes.
Salonen KM; Ryhänen SJ; Forbes JM; Härkönen T; Ilonen J; Laine AP; Groop PH; Knip M;
Diabetes Care; 2014 Jul; 37(7):1975-81. PubMed ID: 24742661
[TBL] [Abstract][Full Text] [Related]
2. Receptor for advanced glycation end-products (RAGE) provides a link between genetic susceptibility and environmental factors in type 1 diabetes.
Forbes JM; Söderlund J; Yap FY; Knip M; Andrikopoulos S; Ilonen J; Simell O; Veijola R; Sourris KC; Coughlan MT; Forsblom C; Slattery R; Grey ST; Wessman M; Yamamoto H; Bierhaus A; Cooper ME; Groop PH
Diabetologia; 2011 May; 54(5):1032-42. PubMed ID: 21298413
[TBL] [Abstract][Full Text] [Related]
3. Risk genes and autoantibodies in Egyptian children with type 1 diabetes - low frequency of autoantibodies in carriers of the HLA-DRB1*04:05-DQA1*03-DQB1*02 risk haplotype.
El-Amir MI; El-Feky MA; Laine AP; Härkönen T; El-Badawy O; Eltayeb AA; El-Melegy TT; Kiviniemi M; Knip M; Ilonen J
Diabetes Metab Res Rev; 2015 Mar; 31(3):287-94. PubMed ID: 25256132
[TBL] [Abstract][Full Text] [Related]
4. Association of polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating RAGE levels.
Gaens KH; Ferreira I; van der Kallen CJ; van Greevenbroek MM; Blaak EE; Feskens EJ; Dekker JM; Nijpels G; Heine RJ; 't Hart LM; de Groot PG; Stehouwer CD; Schalkwijk CG
J Clin Endocrinol Metab; 2009 Dec; 94(12):5174-80. PubMed ID: 19890027
[TBL] [Abstract][Full Text] [Related]
5. Decrease in circulating concentrations of soluble receptors for advanced glycation end products at the time of seroconversion to autoantibody positivity in children with prediabetes.
Salonen KM; Ryhänen SJ; Forbes JM; Borg DJ; Härkönen T; Ilonen J; Simell O; Veijola R; Groop PH; Knip M
Diabetes Care; 2015 Apr; 38(4):665-70. PubMed ID: 25573878
[TBL] [Abstract][Full Text] [Related]
6. Extreme genetic risk for type 1A diabetes.
Aly TA; Ide A; Jahromi MM; Barker JM; Fernando MS; Babu SR; Yu L; Miao D; Erlich HA; Fain PR; Barriga KJ; Norris JM; Rewers MJ; Eisenbarth GS
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14074-9. PubMed ID: 16966600
[TBL] [Abstract][Full Text] [Related]
7. Genetic variants in the receptor for advanced glycation end products (RAGE) gene were associated with circulating soluble RAGE level but not with renal function among Asians with type 2 diabetes: a genome-wide association study.
Lim SC; Dorajoo R; Zhang X; Wang L; Ang SF; Tan CSH; Yeoh LY; Ng XW; Li N; Su C; Liu S; Wong MDS; Low KMS; Yao AO; Babitha J; Fun S; Zhou S; Lee SBM; Tang WE; Tavintharan S; Sum CF; Liu JJ
Nephrol Dial Transplant; 2017 Oct; 32(10):1697-1704. PubMed ID: 27448675
[TBL] [Abstract][Full Text] [Related]
8. AGER gene polymorphisms and soluble receptor for advanced glycation end product in patients with idiopathic pulmonary fibrosis.
Yamaguchi K; Iwamoto H; Horimasu Y; Ohshimo S; Fujitaka K; Hamada H; Mazur W; Kohno N; Hattori N
Respirology; 2017 Jul; 22(5):965-971. PubMed ID: 28198072
[TBL] [Abstract][Full Text] [Related]
9. The influence of age and gender on HLA-DR in Chinese child-onset type 1 diabetes mellitus patients.
Chen BH; Chiang W; Yen JH; Chao MG
Kaohsiung J Med Sci; 2000 Aug; 16(8):393-9. PubMed ID: 11221543
[TBL] [Abstract][Full Text] [Related]
10. Association between plasma sRAGE and emphysema according to the genotypes of AGER gene.
Sin S; Lim MN; Kim J; Bak SH; Kim WJ
BMC Pulm Med; 2022 Feb; 22(1):58. PubMed ID: 35144588
[TBL] [Abstract][Full Text] [Related]
11. SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients.
Sedimbi SK; Luo XR; Sanjeevi CB; ; ; Lernmark A; Landin-Olsson M; Arnqvist H; Björck E; Nyström L; Ohlson LO; Scherstén B; Ostman J; Aili M; Bååth LE; Carlsson E; Edenwall H; Forsander G; Granström BW; Gustavsson I; Hanås R; Hellenberg L; Hellgren H; Holmberg E; Hörnell H; Ivarsson SA; Johansson C; Jonsell G; Kockum K; Lindblad B; Lindh A; Ludvigsson J; Myrdal U; Neiderud J; Segnestam K; Sjöblad S; Skogsberg L; Strömberg L; Ståhle U; Thalme B; Tullus K; Tuvemo T; Wallensteen M; Westphal O; Dahlquist G; Aman J
Genes Immun; 2007 Sep; 8(6):518-21. PubMed ID: 17554341
[TBL] [Abstract][Full Text] [Related]
12. Type 1 diabetes in the Spanish population: additional factors to class II HLA-DR3 and -DR4.
Urcelay E; Santiago JL; de la Calle H; Martínez A; Méndez J; Ibarra JM; Maluenda C; Fernández-Arquero M; de la Concha EG
BMC Genomics; 2005 Apr; 6():56. PubMed ID: 15842729
[TBL] [Abstract][Full Text] [Related]
13. HLA DR phenotypic frequencies and genetic risk of Type 1 diabetes in west region of Algeria, Tlemcen.
Aribi M; Moulessehoul S; Benabadji AB; Kendoucitani M
BMC Genet; 2004 Aug; 5():24. PubMed ID: 15331022
[TBL] [Abstract][Full Text] [Related]
14. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
[TBL] [Abstract][Full Text] [Related]
15. Association of the receptor for advanced glycation end products gene polymorphisms and circulating RAGE levels with diabetic retinopathy in the Chinese population.
Yang L; Wu Q; Li Y; Fan X; Hao Y; Sun H; Cui Y; Han L
J Diabetes Res; 2013; 2013():264579. PubMed ID: 24303504
[TBL] [Abstract][Full Text] [Related]
16. A drop in the circulating concentrations of soluble receptor for advanced glycation end products is associated with seroconversion to autoantibody positivity but not with subsequent progression to clinical disease in children en route to type 1 diabetes.
Salonen KM; Ryhänen SJ; Forbes JM; Härkönen T; Ilonen J; Simell O; Veijola R; Groop PH; Knip M
Diabetes Metab Res Rev; 2017 May; 33(4):. PubMed ID: 27883367
[TBL] [Abstract][Full Text] [Related]
17. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
Hermann R; Gombos Z; Gyürüs E; Soltész G
Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
[TBL] [Abstract][Full Text] [Related]
18. Association of four genetic polymorphisms of AGER and its circulating forms with coronary artery disease: a meta-analysis.
Peng F; Hu D; Jia N; Li X; Li Y; Chu S; Zhu D; Shen W; Lin J; Niu W
PLoS One; 2013; 8(7):e70834. PubMed ID: 23894685
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes.
Salonen KM; Ryhänen S; Härkönen T; Ilonen J; Knip M;
Diabetes Metab Res Rev; 2013 Nov; 29(8):646-54. PubMed ID: 23861236
[TBL] [Abstract][Full Text] [Related]
20. The HLA 8.1 ancestral haplotype is strongly linked to the C allele of -429T>C promoter polymorphism of receptor of the advanced glycation endproduct (RAGE) gene. Haplotype-independent association of the -429C allele with high hemoglobinA1C levels in diabetic patients.
Laki J; Kiszel P; Vatay A; Blaskó B; Kovács M; Körner A; Madácsy L; Blatniczky L; Almássy Z; Szalai C; Rajczy K; Pozsonyi E; Karádi I; Fazakas A; Hosszúfalusi N; Pánczél P; Arason GJ; Wu YL; Zhou B; Yang Y; Yu CY; Füst G
Mol Immunol; 2007 Jan; 44(4):648-55. PubMed ID: 16504296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
